Lead product

Multireceptor somatostatin analog
The lead product of OctreoPharm Sciences GmbH is a multireceptor somatostatin analog, targeting ssr-t 1, 2, 3 and 5

2009    Global, exclusive Option and Licence Agreement for our lead product

2010    Start of preclinical activities

2011    Finalisation of 1st Financing Round

2011    Start of U.S. activities

2011    Start of clinical studies in Europe (expected)


More details on request.